Arca
Skip to content
Tools
Tools

-sertib

Drugs that block serine/threonine kinases.

  • Drugs ending in -sertib: 67
  • Approved somewhere: 1
  • With a US drug page: 2

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-sertib
Class
Drugs that block serine/threonine kinases

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -sertib, matched by spelling; those with a US drug page link to it.
Acts on
CapivasertibApprovedSerine/threonine-protein kinase AKTSerine/threonine-protein kinase AKT inhibitor
ZilurgisertibPhase 2——
AfuresertibPhase 3Serine/threonine-protein kinase AKTSerine/threonine-protein kinase AKT inhibitor
AlisertibPhase 3AURKASerine/threonine-protein kinase Aurora-A inhibitor
CeralasertibPhase 3ATRSerine-protein kinase ATR inhibitor
IbcasertibPhase 3AURKB, Vascular endothelial growth factor receptorSerine/threonine-protein kinase Aurora-B inhibitor
IpatasertibPhase 3Serine/threonine-protein kinase AKTSerine/threonine-protein kinase AKT inhibitor
RigosertibPhase 3——
SelonsertibPhase 3MAP3K5Mitogen-activated protein kinase kinase kinase 5 inhibitor
VolasertibPhase 3PLK1Serine/threonine-protein kinase PLK1 inhibitor
AdavosertibPhase 2WEE1Serine/threonine-protein kinase WEE1 inhibitor
AmcasertibPhase 2——
AzenosertibPhase 2WEE1Serine/threonine-protein kinase WEE1 inhibitor
BarasertibPhase 2AURKBSerine/threonine-protein kinase Aurora-B inhibitor
BerzosertibPhase 2ATRSerine-protein kinase ATR inhibitor
CamonsertibPhase 2——
DanusertibPhase 2Serine/threonine-protein kinase AuroraSerine/threonine-protein kinase Aurora inhibitor
DapolsertibPhase 2——
DarovasertibPhase 2——
DefosbarasertibPhase 2——
DelcasertibPhase 2PRKCDProtein kinase C delta inhibitor
EclitasertibPhase 2——
EdecesertibPhase 2——
FidrisertibPhase 2——
GalunisertibPhase 2TGFBR1TGF-beta receptor type I inhibitor
IlorasertibPhase 2Serine/threonine-protein kinase Aurora, Vascular endothelial growth factor receptor, SRC, PDGFRA, PDGFRBSerine/threonine-protein kinase Aurora inhibitor
InlexisertibPhase 2——
LartesertibPhase 2——
LunresertibPhase 2——
LuvixasertibPhase 2——
MiransertibPhase 2Serine/threonine-protein kinase AKTSerine/threonine-protein kinase AKT inhibitor
MonzosertibPhase 2——
NuvisertibPhase 2——
OcifisertibPhase 2PLK4Serine/threonine-protein kinase PLK4 inhibitor
OditrasertibPhase 2——
OnatasertibPhase 2MTORSerine/threonine-protein kinase mTOR inhibitor
OnvansertibPhase 2PLK1Serine/threonine-protein kinase PLK1 inhibitor
PadnarsertibPhase 2——
PifusertibPhase 2Serine/threonine-protein kinase AKTSerine/threonine-protein kinase AKT negative allosteric modulator
PimasertibPhase 2MAP2K1, MAP2K2Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
PlogosertibPhase 2——
PotrasertibPhase 2——
PrexasertibPhase 2CHEK1, CHEK2Serine/threonine-protein kinase Chk1 inhibitor
RabusertibPhase 2CHEK1Serine/threonine-protein kinase Chk1 inhibitor
RupitasertibPhase 2AKT1, AKT3, RPS6KB1, RPS6KB2Serine/threonine-protein kinase AKT inhibitor
SapanisertibPhase 2MTORSerine/threonine-protein kinase mTOR inhibitor
SilmitasertibPhase 2CSNK2A1Casein kinase II alpha inhibitor
TanzisertibPhase 2MAPK8, MAPK9, MAPK10c-Jun N-terminal kinase 1 inhibitor
TilpisertibPhase 2MAP3K8Mitogen-activated protein kinase kinase kinase 8 inhibitor
Tilpisertib fosmecarbilPhase 2——
TinodasertibPhase 2——
TomivosertibPhase 2MKNK1, MKNK2MAP kinase-interacting serine/threonine-protein kinase 1/2 inhibitor
TozasertibPhase 2Serine/threonine-protein kinase AuroraSerine/threonine-protein kinase Aurora inhibitor
TuvusertibPhase 2——
UprosertibPhase 2Serine/threonine-protein kinase AKTSerine/threonine-protein kinase AKT inhibitor
VactosertibPhase 2TGFBR1TGF-beta receptor type I inhibitor
VistusertibPhase 2MTORSerine/threonine-protein kinase mTOR inhibitor
ZimlovisertibPhase 2IRAK4Interleukin-1 receptor-associated kinase 4 inhibitor
CafusertibPhase 1PLK1Serine/threonine-protein kinase PLK1 inhibitor
CenisertibPhase 1Serine/threonine-protein kinase AuroraSerine/threonine-protein kinase Aurora inhibitor
ElimusertibPhase 1ATRSerine-protein kinase ATR inhibitor
EmavusertibPhase 1——
FlizasertibPhase 1——
NedisertibPhase 1——
OcadusertibPhase 1——
SimurosertibPhase 1CDC7Cell division cycle 7-related protein kinase inhibitor
VevorisertibPhase 1——

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.